These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 35469839)
1. Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer. Wei Y; Zhu Z; Hu H; Guan J; Yang B; Zhao H Eur J Pharmacol; 2022 Jun; 924():174970. PubMed ID: 35469839 [TBL] [Abstract][Full Text] [Related]
2. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells. Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043 [TBL] [Abstract][Full Text] [Related]
3. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells. Wen Y; Chen H; Zhang L; Wu M; Zhang F; Yang D; Shen J; Chen J Free Radic Biol Med; 2021 Sep; 173():41-51. PubMed ID: 34271106 [TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669 [TBL] [Abstract][Full Text] [Related]
5. Novel Withanolides from Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657 [TBL] [Abstract][Full Text] [Related]
6. G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis. Sun G; Wang J; Liu F; Zhao C; Cui S; Wang Z; Liu Z; Zhang Q; Xiang C; Zhang Y; Galons H; Yu P; Teng Y Biochem Pharmacol; 2024 Apr; 222():116077. PubMed ID: 38395264 [TBL] [Abstract][Full Text] [Related]
7. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis. Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625 [TBL] [Abstract][Full Text] [Related]
8. Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Dibra D; Xiong S; Moyer SM; El-Naggar AK; Qi Y; Su X; Kong EK; Korkut A; Lozano G Sci Adv; 2024 Feb; 10(7):eadk1835. PubMed ID: 38354236 [TBL] [Abstract][Full Text] [Related]
9. Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells. Luo Y; Gao X; Zou L; Lei M; Feng J; Hu Z Oxid Med Cell Longev; 2021; 2021():1783485. PubMed ID: 34707773 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940 [TBL] [Abstract][Full Text] [Related]
11. Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells. He C; Wang C; Liu H; Shan B BMC Cancer; 2022 Jul; 22(1):724. PubMed ID: 35778693 [TBL] [Abstract][Full Text] [Related]
12. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231. Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913 [TBL] [Abstract][Full Text] [Related]
13. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Zhou C; Yu T; Zhu R; Lu J; Ouyang X; Zhang Z; Chen Q; Li J; Cui J; Jiang F; Jin KY; Sarapultsev A; Li F; Zhang G; Luo S; Hu D Int J Biol Sci; 2023; 19(5):1471-1489. PubMed ID: 37056925 [TBL] [Abstract][Full Text] [Related]
14. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis. Song X; Wang X; Chen X; Yu Z; Zhou Y J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194 [TBL] [Abstract][Full Text] [Related]
15. Treatment with the Ferroptosis Inhibitor Ferrostatin-1 Attenuates Noise-Induced Hearing Loss by Suppressing Ferroptosis and Apoptosis. Ma PW; Wang WL; Chen JW; Yuan H; Lu PH; Gao W; Ding XR; Lun YQ; Liang R; He ZH; Yang Q; Lu LJ Oxid Med Cell Longev; 2022; 2022():3373828. PubMed ID: 36531206 [TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-d-ribose induces ferroptosis in renal tubular epithelial cells via ubiquitin-proteasome system-mediated xCT protein degradation. Kim M; Bae JY; Yoo S; Kim HW; Lee SA; Kim ET; Koh G Free Radic Biol Med; 2023 Nov; 208():384-393. PubMed ID: 37659699 [TBL] [Abstract][Full Text] [Related]
17. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells. Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931 [TBL] [Abstract][Full Text] [Related]
18. p53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides. Zhang Y; Xia M; Zhou Z; Hu X; Wang J; Zhang M; Li Y; Sun L; Chen F; Yu H Int J Nanomedicine; 2021; 16():283-296. PubMed ID: 33469287 [TBL] [Abstract][Full Text] [Related]
19. Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007. Synnott NC; Bauer MR; Madden S; Murray A; Klinger R; O'Donovan N; O'Connor D; Gallagher WM; Crown J; Fersht AR; Duffy MJ Cancer Lett; 2018 Feb; 414():99-106. PubMed ID: 29069577 [TBL] [Abstract][Full Text] [Related]
20. A Mitochondria-Targeted Ferroptosis Inducer Activated by Glutathione-Responsive Imaging and Depletion for Triple Negative Breast Cancer Theranostics. Gan H; Huang X; Luo X; Li J; Mo B; Cheng L; Shu Q; Du Z; Tang H; Sun W; Wang L; Luo S; Yu S Adv Healthc Mater; 2023 Sep; 12(22):e2300220. PubMed ID: 37204240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]